FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Steven Potkin

Research Profile

Disorders

Chemicals & Drugs

Procedures

Activities & Behaviors

Schizophrenic Psychology

Anatomy

Concepts & Ideas

Genes & Molecular Sequences

Single Nucleotide Polymorphism

Physiology

Co-author Network

Publications

TOP 3
Julie V. Patterson; Steven G Potkin; Curt A Sandman; Yi Jin; Aaron S Kemp; William E Bunney
Gating of a novel brain potential is associated with perceptual anomalies in bipolar disorder.
Antony Loebel; Andrei Pikalov; Josephine Cucchiaro; Chuanchieh Hsu; Amir H Kalali; Kaushik Sarma; Lei Xu; Steven G Potkin
Efficacy and safety of lurasidone 80 mg/day and 160 mg/day in the treatment of schizophrenia: a randomized, double-blind, placebo- and active-controlled trial.
Emily M Sontag; Zhiqun Tan; Anthony Tomlinson; Judith Frydman; Charles G Glabe; David E Housman; Lukasz A Joachimiak; Steven G Potkin; Leslie M Thompson
Exogenous delivery of chaperonin subunit fragment ApiCCT1 modulates mutant Huntingtin cellular phenotypes.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Steven Potkin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Julie V. Patterson; Steven G Potkin; Curt A Sandman; Yi Jin; Aaron S Kemp; William E Bunney
Gating of a novel brain potential is associated with perceptual anomalies in bipolar disorder.
Bipolar disorders 2013;15(3):314-25.
2013: Antony Loebel; Andrei Pikalov; Josephine Cucchiaro; Chuanchieh Hsu; Amir H Kalali; Kaushik Sarma; Lei Xu; Steven G Potkin
Efficacy and safety of lurasidone 80 mg/day and 160 mg/day in the treatment of schizophrenia: a randomized, double-blind, placebo- and active-controlled trial.
Schizophrenia research 2013;145(1-3):101-9.
2013: Emily M Sontag; Zhiqun Tan; Anthony Tomlinson; Judith Frydman; Charles G Glabe; David E Housman; Lukasz A Joachimiak; Steven G Potkin; Leslie M Thompson
Exogenous delivery of chaperonin subunit fragment ApiCCT1 modulates mutant Huntingtin cellular phenotypes.
Proceedings of the National Academy of Sciences of the United States of America 2013;110(8):3077-82.
2013: Steven G Potkin; Sheldon Preskorn; Marla Hochfeld; Xiangyi Meng
A Thorough QTc study of 3 doses of iloperidone including metabolic inhibition via CYP2D6 and/or CYP3A4 and a comparison to quetiapine and ziprasidone.
Journal of clinical psychopharmacology 2013;33(1):3-10.
2012: Gwyneth Zai; Nabilah I Chowdhury; Jeffrey A Lieberman; Herbert Y Meltzer; Daniel J Müller; Steven G Potkin; Renan Souza; Arun K Tiwari; Clement Zai; James L Kennedy
The role of brain-derived neurotrophic factor (BDNF) gene variants in antipsychotic response and antipsychotic-induced weight gain.
Progress in neuro-psychopharmacology & biological psychiatry 2012;39(1):96-101.
2012: Yi Jin; Aaron S Kemp; Zhaorui Liu; Hua He; Yueqin Huang; Trung Minh Thai; Wanjiao Xu; Steven G Potkin
Alpha EEG guided TMS in schizophrenia.
Brain stimulation 2012;5(4):560-8.
2012: Gary H Glover; Douglas N Greve; David B Keator; Hyo Jong Lee; Kelvin O Lim; Thomas T Liu; Daniel H Mathalon; Gregory McCarthy; Bryon A Mueller; Daniel S O'Leary; Burak Ozyurt; Aysenil Belger; Gregory G Brown; Vince D Calhoun; Michele Diaz; Judith M Ford; Syam Gadde; Adrian Preda; Jerod Rasmussen; Hal S Stern; Jessica A Turner; Theo G M van Erp; James T Voyvodic; Cynthia G Wible; Steven G Potkin
Function biomedical informatics research network recommendations for prospective multicenter functional MRI studies.
Journal of magnetic resonance imaging : JMRI 2012;36(1):39-54.
2012: Jessica A Turner; Theo G M van Erp; Juan Bustillo; Vince D Calhoun; John Csernansky; Stefan Ehrlich; Randy L Gollub; Beng-Choon Ho; Andrew Michael; Steven G Potkin; S Charles Schulz; Judith M Segall; Lei Wang
Heritability of multivariate gray matter measures in schizophrenia.
Twin research and human genetics : the official journal of the International Society for Twin Studies 2012;15(3):324-35.
2012: Arun K Tiwari; A N Voineskos; Clement Zai; Jeffrey A Lieberman; Olga Likhodi; Herbert Y Meltzer; Daniel J Müller; Steven G Potkin; Gary Remington; James L Kennedy
Association study of cannabinoid receptor 1 (CNR1) gene in tardive dyskinesia.
The pharmacogenomics journal 2012;12(3):260-6.
2012: Rudi Hwang; Daniel Felsky; Jeffrey A Lieberman; Herbert Y Meltzer; Gabriel Oh; Steven G Potkin; Eli Remington; Renan Souza; Arun K Tiwari; Ryan P Tong; Tessa Wallace; Clement Zai; James L Kennedy
Dopamine D4 and D5 receptor gene variant effects on clozapine response in schizophrenia: replication and exploration.
Progress in neuro-psychopharmacology & biological psychiatry 2012;37(1):62-75.
2012: Jerod M Rasmussen; Theo G M van Erp; James T Fallon; David Keator; Frithjof Kruggel; Anita Lakatos; Fabio Macciardi; Steven G Potkin
Empirical derivation of the reference region for computing diagnostic sensitive ¹⁸fluorodeoxyglucose ratios in Alzheimer's disease based on the ADNI sample.
Biochimica et biophysica acta 2012;1822(3):457-66.
2012: Shanker Swaminathan; Michael W Weiner; John D West; Karmen K Yoder; David Craig; Tatiana Foroud; Matthew Huentelman; Mark Inlow; Clifford R Jack; William J Jagust; Sungeun Kim; Robert A Koeppe; Chester A Mathis; Kwangsik Nho; Steven G Potkin; Shannon L Risacher; Andrew J. Saykin; Li Shen
Amyloid pathway-based candidate gene analysis of [(11)C]PiB-PET in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort.
Brain imaging and behavior 2012;6(1):1-15.
2012: Ann L Chervenak; Lisa Dahm; Mike D'Arcy; Anton Hasso; David Keator; Carl Kesselman; Meng Law; Fabio Macciardi; Jim Murry; Janet Sobell; Theo G M van Erp; Joseph Ames; Steven G Potkin
A system architecture for sharing de-identified, research-ready brain scans and health information across clinical imaging centers.
Studies in health technology and informatics 2012;175():19-28.
2012: Jingyu Liu; Fabio Macciardi; Daniel H Mathalon; Andrew M Michael; Nora Perrone-Bizzozero; Steven G Potkin; Jessica A Turner; William Wells; David Boutte; Judith M Ford; Mohammad M Ghassemi; Vince D Calhoun
An ICA with reference approach in identification of genetic variation and associated brain networks.
Frontiers in human neuroscience 2012;6():21.
2011: Tristram A P Lett; Jeffrey A Lieberman; Herbert Y Meltzer; Steven G Potkin; Arun K Tiwari; Aristotle N Voineskos; James L Kennedy; Daniel J Müller
The putative functional rs1045881 marker of neurexin-1 in schizophrenia and clozapine response.
Schizophrenia research 2011;132(2-3):121-4.
2011: Steven G Potkin; Masaaki Ogasa; Josephine Cucchiaro; Antony Loebel
Double-blind comparison of the safety and efficacy of lurasidone and ziprasidone in clinically stable outpatients with schizophrenia or schizoaffective disorder.
Schizophrenia research 2011;132(2-3):101-7.
2011: Steven Mee; Steven G Potkin; Blynn G Bunney; William E Bunney; William Hetrick; Christopher Reist
Assessment of psychological pain in major depressive episodes.
Journal of psychiatric research 2011;45(11):1504-10.
2011: Derrek P Hibar; Matthew Huentelman; Clifford R Jack; Neda Jahanshad; Sungeun Kim; Omid Kohannim; Nathan Pankratz; Steven G Potkin; Andrew J. Saykin; Li Shen; Jason L Stein; Paul M Thompson; Arthur W Toga; Michael W Weiner; Tatiana Foroud
Voxelwise gene-wide association study (vGeneWAS): multivariate gene-based association testing in 731 elderly subjects.
NeuroImage 2011;56(4):1875-91.
2011: Douglas N Greve; Bryon A Mueller; Thomas Liu; Jessica Turner; James Voyvodic; Elizabeth Yetter; Michele Diaz; Gregory McCarthy; Stuart Wallace; Brian J Roach; Judy M Ford; Daniel H Mathalon; Vince D Calhoun; Cynthia G Wible; Gregory G Brown; Steven G Potkin; Gary Glover
A novel method for quantifying scanner instability in fMRI.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 2011;65(4):1053-61.
2011: Rudi Hwang; Renan Souza; Arun K Tiwari; Clement C Zai; Daniel J Müller; Steven G Potkin; Jeffrey A Lieberman; Herbert Y Meltze; James L Kennedy
Gene-gene interaction analyses between NMDA receptor subunit and dopamine receptor gene variants and clozapine response.
Pharmacogenomics 2011;12(2):277-91.
2011: Gregory G Brown; Daniel H Mathalon; Hal Stern; Judith Ford; Bryon Mueller; Douglas N Greve; Gregory McCarthy; James Voyvodic; Gary Glover; Michele Diaz; Elizabeth Yetter; I Burak Ozyurt; Kasper W Jorgensen; Cynthia G Wible; Jessica Turner; Wesley K Thompson; Steven G Potkin
Multisite reliability of cognitive BOLD data.
NeuroImage 2011;54(3):2163-75.
2011: John M Kane; Steven G Potkin; David G Daniel; Peter F Buckley
A double-blind, randomized study comparing the efficacy and safety of sertindole and risperidone in patients with treatment-resistant schizophrenia.
The Journal of clinical psychiatry 2011;72(2):194-204.
2011: S Kim; S Swaminathan; L Shen; S L Risacher; K Nho; Tatiana Foroud; L M Shaw; John Q Trojanowski; Steven G Potkin; Matthew Huentelman; David Craig; Bryan M Dechairo; P S Aisen; Ronald C. Petersen; Michael Weiner; Andrew J. Saykin
Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort.
Neurology 2011;76(1):69-79.
2011: Shanker Swaminathan; Michael W Weiner; David Craig; Tatiana Foroud; Matthew Huentelman; Sungeun Kim; Nathan Pankratz; Steven G Potkin; Shannon L Risacher; Andrew J Saykin; Li Shen
Genomic Copy Number Analysis in Alzheimer's Disease and Mild Cognitive Impairment: An ADNI Study.
International journal of Alzheimer's disease 2011;2011():729478.
2011: Lingjie Weng; Fabio Macciardi; Aravind Subramanian; Guia Guffanti; Steven G Potkin; Zhaoxia Yu; Xiaohui Xie
SNP-based pathway enrichment analysis for genome-wide association studies.
BMC bioinformatics 2011;12():99.
2010: Steven G Potkin; Fabio Macciardi; Guia Guffanti; James H Fallon; Qi Wang; Jessica Turner; Anita Lakatos; Michael F Miles; Arthur Lander; Marquis P Vawter; Xiaohui Xie
Identifying gene regulatory networks in schizophrenia.
NeuroImage 2010;53(3):839-47.
2010: Jason L Stein; Xue Hua; Suh Lee; April J Ho; Alex D Leow; Arthur W Toga; Andrew J. Saykin; Li Shen; Tatiana Foroud; Nathan Pankratz; Matthew Huentelman; David Craig; Jill D Gerber; April N Allen; Jason J Corneveaux; Bryan M Dechairo; Steven G Potkin; Michael Weiner; Paul Thompson
Voxelwise genome-wide association study (vGWAS).
NeuroImage 2010;53(3):1160-74.
2010: Li Shen; Sungeun Kim; Shannon L Risacher; Kwangsik Nho; Shanker Swaminathan; John D West; Tatiana Foroud; Nathan Pankratz; Jason H Moore; Chantel D Sloan; Matthew Huentelman; David Craig; Bryan M Dechairo; Steven G Potkin; Clifford R Jack; Michael Weiner; Andrew J. Saykin
Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort.
NeuroImage 2010;53(3):1051-63.
2010: Steven G Potkin; Adrian Preda; Amir H Kalali; Philip D Harvey
Using new antipsychotics in your clinical practice.
The Journal of clinical psychiatry 2010;71(10):e101.
2010: Clement Zai; Arun K Tiwari; Daniel J Müller; Vincenzo De Luca; Takahiro Shinkai; Sajid Shaikh; Xingqun Ni; David Sibony; Aristotle N Voineskos; Herbert Y Meltzer; Jeffrey A Lieberman; Steven G Potkin; Gary Remington; James L Kennedy
The catechol-O-methyl-transferase gene in tardive dyskinesia.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2010;11(6):803-12.
2010: Stephen M Stahl; Ashok Malla; John W Newcomer; Steven G Potkin; Peter Weiden; Philip D Harvey; Antony Loebel; Eric J Watsky; Cynthia O Siu; Steve Romano
A post hoc analysis of negative symptoms and psychosocial function in patients with schizophrenia: a 40-week randomized, double-blind study of ziprasidone versus haloperidol followed by a 3-year double-blind extension trial.
Journal of clinical psychopharmacology 2010;30(4):425-30.
2010: Anita Lakatos; Olga Derbeneva; Danny Younes; David Keator; Trygve Bakken; Maria Lvova; Marty Brandon; Guia Guffanti; Dora Reglodi; Andrew J. Saykin; Michael Weiner; Fabio Macciardi; Nicholas Schork; Douglas C Wallace; Steven G Potkin
Association between mitochondrial DNA variations and Alzheimer's disease in the ADNI cohort.
Neurobiology of aging 2010;31(8):1355-63.
2010: Jason L Stein; Xue Hua; Jonathan H Morra; Sarpong Mr.Samuel; Derrek P Hibar; April J Ho; Alex D Leow; Arthur W Toga; Jae Hoon Sul; Hyun Min Kang; Eleazar Eskin; Andrew J Saykin; Li Shen; Tatiana Foroud; Nathan Pankratz; Matthew Huentelman; David Craig; Jill D Gerber; April N Allen; Jason J Corneveaux; Dietrich A Stephan; Jennifer Webster; Bryan M Dechairo; Steven G Potkin; Clifford R Jack; Michael Weiner; Paul M Thompson
Genome-wide analysis reveals novel genes influencing temporal lobe structure with relevance to neurodegeneration in Alzheimer's disease.
NeuroImage 2010;51(2):542-54.
2010: Rudi Hwang; Clement Zai; Arun K Tiwari; Daniel J Müller; Maria J Arranz; A G Morris; P J McKenna; J Munro; Steven G Potkin; Jeffrey A Lieberman; Herbert Y Meltzer; James L Kennedy
Effect of dopamine D3 receptor gene polymorphisms and clozapine treatment response: exploratory analysis of nine polymorphisms and meta-analysis of the Ser9Gly variant.
The pharmacogenomics journal 2010;10(3):200-18.
2010: April J Ho; Jason L Stein; Xue Hua; Sarpong Mr.Samuel; Derrek P Hibar; Alex D Leow; Ivo D Dinov; Arthur W Toga; Andrew J Saykin; Li Shen; Tatiana Foroud; Nathan Pankratz; Matthew Huentelman; David Craig; Jill D Gerber; April N Allen; Jason J Corneveaux; Dietrich A Stephan; Charles DeCarli; Bryan M Dechairo; Steven G Potkin; Clifford R Jack; Michael Weiner; Cyrus A Raji; Oscar L Lopez; James Becker; Owen T Carmichael; Paul M Thompson
A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(18):8404-9.
2010: Andrew J. Saykin; Li Shen; Tatiana M Foroud; Steven G Potkin; Shanker Swaminathan; Sungeun Kim; Shannon L Risacher; Kwangsik Nho; Matthew Huentelman; David Craig; Paul M Thompson; Jason L Stein; Jason H Moore; Lindsay A Farrer; Robert C Green; Lars Bertram; Clifford R Jack; Michael Weiner
Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2010;6(3):265-73.
2010: Aaron S Kemp; Nina R Schooler; Amir H Kalali; Larry Alphs; Ravi Anand; George Awad; Michael Davidson; Sanjay Dubé; Larry Ereshefsky; Georges Gharabawi; Andrew C Leon; Jean-Pierre Lepine; Steven G Potkin; An Vermeulen
What is causing the reduced drug-placebo difference in recent schizophrenia clinical trials and what can be done about it?
Schizophrenia bulletin 2010;36(3):504-9.
2010: Miyoung A Kim; Emanuela Tura; Steven G Potkin; James H Fallon; Dara S Manoach; Vince D Calhoun; Jessica Turner
Working memory circuitry in schizophrenia shows widespread cortical inefficiency and compensation.
Schizophrenia research 2010;117(1):42-51.
2010: Gabriela Novak; Alexandra Gallo; Clement Zai; Herbert Y Meltzer; Jeffrey A Lieberman; Steven G Potkin; Aristotle N Voineskos; Gary Remington; James L Kennedy; Daniel Levesque; Bernard Le Foll
Association of the orphan nuclear receptor NR4A1 with tardive dyskinesia.
Psychiatric genetics 2010;20(1):39-43.
2010: Clement Zai; Arun K Tiwari; Vincenzo S Basile; Vincenzo De Luca; Daniel J Müller; Aristotle N Voineskos; Gary Remington; Herbert Y Meltzer; Jeffrey A Lieberman; Steven G Potkin; James L Kennedy
Oxidative stress in tardive dyskinesia: genetic association study and meta-analysis of NADPH quinine oxidoreductase 1 (NQO1) and Superoxide dismutase 2 (SOD2, MnSOD) genes.
Progress in neuro-psychopharmacology & biological psychiatry 2010;34(1):50-6.
2009: Steven G Potkin; Cynthia O Siu
Dropouts and missing data in psychiatric clinical trials.
The American journal of psychiatry 2009;166(11):1295; author reply 1295-6.
2009: Steven G Potkin; Peter Weiden; Antony D Loebel; Lewis E Warrington; Eric J Watsky; Cynthia O Siu
Remission in schizophrenia: 196-week, double-blind treatment with ziprasidone vs. haloperidol.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2009;12(9):1233-48.
2009: Joseph C Wu; John R Kelsoe; Carol Schachat; Blynn G Bunney; Anna DeModena; Shahrokh Golshan; J Christian Gillin; Steven G Potkin; William E Bunney
Rapid and sustained antidepressant response with sleep deprivation and chronotherapy in bipolar disorder.
Biological psychiatry 2009;66(3):298-301.
2009: Simona Volpi; Steven G Potkin; Anil Malhotra; Louis Licamele; Christian Lavedan
Applicability of a genetic signature for enhanced iloperidone efficacy in the treatment of schizophrenia.
The Journal of clinical psychiatry 2009;70(6):801-9.
2009: Clement Zai; Arun K Tiwari; Vincenzo S Basile; Vincenzo De Luca; Daniel J Müller; Nicole King; A N Voineskos; Gary Remington; Herbert Y Meltzer; Jeffrey A Lieberman; Steven G Potkin; James L Kennedy
Association study of tardive dyskinesia and five DRD4 polymorphisms in schizophrenia patients.
The pharmacogenomics journal 2009;9(3):168-74.
2009: Vincenzo De Luca; Renan Souza; Emanuella Viggiano; Clement Zai; Takahiro Shinkai; Jeffrey A Lieberman; Steven G Potkin; Herbert Y Meltzer; Gary Remington; James L Kennedy
MDR1 gene in tardive dyskinesia scale scores: comparison of strategies for quantitative trait haplotype analysis.
Schizophrenia research 2009;110(1-3):200-1.
2009: Clement Zai; Arun K Tiwari; Vincenzo De Luca; Daniel J Müller; Natalie Bulgin; Rudi Hwang; Gwyneth C Zai; Nicole King; Aristotle N Voineskos; Herbert Y Meltzer; Jeffrey A Lieberman; Steven G Potkin; Gary Remington; James L Kennedy
Genetic study of BDNF, DRD3, and their interaction in tardive dyskinesia.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2009;19(5):317-28.
2009: Steven G Potkin; Jessica Turner; J A Fallon; A Lakatos; David Keator; G Guffanti; Fabio Macciardi
Gene discovery through imaging genetics: identification of two novel genes associated with schizophrenia.
Molecular psychiatry 2009;14(4):416-28.
2009: Jonathan M Silver; Barbara Koumaras; Xiangyi Meng; Steven G Potkin; Patricio Reyes; Philip D Harvey; Douglas I Katz; Ibrahim Gunay; David B Arciniegas
Long-term effects of rivastigmine capsules in patients with traumatic brain injury.
Brain injury : [BI] 2009;23(2):123-32.
2009: Steven G Potkin; Guia Guffanti; Anita Lakatos; Jessica Turner; Frithjof Kruggel; James H Fallon; Andrew J. Saykin; Alessandro Orro; Sara Lupoli; Erika Salvi; Michael Weiner; Fabio Macciardi
Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease.
PloS one 2009;4(8):e6501.
2009: Steven G Potkin; Jessica Turner; Guia Guffanti; Anita Lakatos; Federica Torri; David Keator; Fabio Macciardi
Genome-wide strategies for discovering genetic influences on cognition and cognitive disorders: methodological considerations.
Cognitive neuropsychiatry 2009;14(4-5):391-418.
2009: Jean Gehricke; Steven G Potkin; Frances M Leslie; Sandra E Loughlin; Carol K Whalen; Larry D Jamner; James Mbogori; James H Fallon
Nicotine-induced brain metabolism associated with anger provocation.
Behavioral and brain functions : BBF 2009;5():19.
2008: Clement Zai; Marco A Romano-Silva; Rudi Hwang; Gwyneth C Zai; Vincenzo Deluca; Daniel J Müller; Nicole King; Aristotle N Voineskos; Herbert Y Meltzer; Jeffrey A Lieberman; Steven G Potkin; Gary Remington; James L Kennedy
Genetic study of eight AKT1 gene polymorphisms and their interaction with DRD2 gene polymorphisms in tardive dyskinesia.
Schizophrenia research 2008;106(2-3):248-52.
2008: Lee Friedman; Hal Stern; Gregory G Brown; Daniel H Mathalon; Jessica Turner; Gary H Glover; Randy L Gollub; John Lauriello; Kelvin O Lim; Tyrone Cannon; Douglas N Greve; henry bockholt; Aysenil Belger; Bryon Mueller; Michael J Doty; Jianchun He; William Wells; Padhraic Smyth; Steve Pieper; Seyoung Kim; Marek Kubicki; Mark Vangel; Steven G Potkin
Test-retest and between-site reliability in a multicenter fMRI study.
Human brain mapping 2008;29(8):958-72.
2008: Emanuela Tura; Jessica Turner; James H Fallon; James L Kennedy; Steven G Potkin
Multivariate analyses suggest genetic impacts on neurocircuitry in schizophrenia.
Neuroreport 2008;19(6):603-7.
2008: Lee Friedman; Jessica Turner; Hal Stern; Daniel H Mathalon; Liv C Trondsen; Steven G Potkin
Chronic smoking and the BOLD response to a visual activation task and a breath hold task in patients with schizophrenia and healthy controls.
NeuroImage 2008;40(3):1181-94.
2008: Steven G Potkin; Robert E Litman; Rosarelis Torres; Curt D Wolfgang
Efficacy of iloperidone in the treatment of schizophrenia: initial phase 3 studies.
Journal of clinical psychopharmacology 2008;28(2 Suppl 1):S4-11.
2008: Steven G Potkin
New advances in the treatment of schizophrenia. Introduction.
Journal of clinical psychopharmacology 2008;28(2 Suppl 1):S1-3.
2008: Julie V. Patterson; WP Hetrick; Nashaat N Boutros; Yi Jin; Curt A Sandman; Hal Stern; Steven G Potkin; William E Bunney
P50 sensory gating ratios in schizophrenics and controls: a review and data analysis.
Psychiatry research 2008;158(2):226-47.
2008: Jennifer N Bunney; Steven G Potkin
Circadian abnormalities, molecular clock genes and chronobiological treatments in depression.
British medical bulletin 2008;86():23-32.
2007: Jean Gehricke; Sandra E Loughlin; Carol K Whalen; Steven G Potkin; James H Fallon; Larry D Jamner; James D Belluzzi; Frances M Leslie
Smoking to self-medicate attentional and emotional dysfunctions.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 2007;9 Suppl 4():S523-36.
2007: Steven G Potkin; Miriam Cohen; John Panagides
Efficacy and tolerability of asenapine in acute schizophrenia: a placebo- and risperidone-controlled trial.
The Journal of clinical psychiatry 2007;68(10):1492-500.
2007: Clement Zai; Rudi Hwang; Vincenzo De Luca; Daniel J Müller; Nicole King; Gwyneth C Zai; Gary Remington; Herbert Y Meltzer; Jeffrey A Lieberman; Steven G Potkin; James L Kennedy
Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2007;10(5):639-51.
2007: Antony Loebel; Sumant Khanna; Sunita Rajadhyaksha; Cynthia O Siu; Earl Giller; Steven G Potkin
Ziprasidone in treatment-resistant schizophrenia: a 52-week, open-label continuation study.
The Journal of clinical psychiatry 2007;68(9):1333-8.
2007: Rudi Hwang; Takahiro Shinkai; Vincenzo De Luca; Xingqun Ni; Steven G Potkin; Jeffrey A Lieberman; Herbert Y Meltzer; James L Kennedy
Association study of four dopamine D1 receptor gene polymorphisms and clozapine treatment response.
Journal of psychopharmacology (Oxford, England) 2007;21(7):718-27.
2007: Mary E Atz; David Walsh; Preston Cartagena; Jun Li; Simon J Evans; Prabhakara V Choudary; Kevin Overman; Richard Stein; Hiro Tomita; Steven G Potkin; Rick Myers; Stanley J Watson Jr; Edward G Jones; Huda Akil; William E Bunney; Marquis P Vawter
Methodological considerations for gene expression profiling of human brain.
Journal of neuroscience methods 2007;163(2):295-309.
2007: Howard H Feldman; Steven H Ferris; Bengt Winblad; Nikolaos Sfikas; Linda Mancione; Yunsheng He; Sibel Tekin; Alistair Burns; Jeffrey L Cummings; Teodoro del Ser; Domenico Inzitari; Jean-Marc Orgogozo; Heinrich Sauer; Philip scheltens; Elio Scarpini; Nathan Herrmann; Martin R Farlow; Steven G Potkin; H Cecil Charles; Nick C Fox; Roger Lane
Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study.
Lancet neurology 2007;6(6):501-12.
2007: Balasubramaniam Easwaramoorthy; Rama Pichika; Daphne Collins; Steven G Potkin; Frances M Leslie; Jogeshwar Mukherjee
Effect of acetylcholinesterase inhibitors on the binding of nicotinic alpha4beta2 receptor PET radiotracer, (18)F-nifene: A measure of acetylcholine competition.
Synapse (New York, N.Y.) 2007;61(1):29-36.
2006: Steven Mee; Blynn G Bunney; Christopher Reist; Steven G Potkin; William E Bunney
Psychological pain: a review of evidence.
Journal of psychiatric research 2006;40(8):680-90.
2006: Neil Saigal; Rama Pichika; Balasubramaniam Easwaramoorthy; Daphne Collins; Bradley T Christian; Bingzhi Shi; Tanjore K Narayanan; Steven G Potkin; Jogeshwar Mukherjee
Synthesis and biologic evaluation of a novel serotonin 5-HT1A receptor radioligand, 18F-labeled mefway, in rodents and imaging by PET in a nonhuman primate.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(10):1697-706.
2006: Jonathan M Silver; Barbara Koumaras; Michael Chen; Dario Mirski; Steven G Potkin; Patricio Reyes; Deborah L Warden; Philip D Harvey; D Arciniegas; Douglas I Katz; Ibrahim Gunay
Effects of rivastigmine on cognitive function in patients with traumatic brain injury.
Neurology 2006;67(5):748-55.
2006: Yi Jin; James P O'Halloran; Lawrence Plon; Curt A Sandman; Steven G Potkin
Alpha EEG predicts visual reaction time.
The International journal of neuroscience 2006;116(9):1035-44.
2006: Elaine Peskind; Steven G Potkin; Nunzio Pomara; Brian R Ott; Stephen M Graham; Jason T Olin; Scott McDonald
Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2006;14(8):704-15.
2006: Swaraj Bose; A C Mok; James H Fallon; Steven G Potkin
Three-month change in cerebral glucose metabolism in patients with nonarteritic ischemic optic neuropathy.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie 2006;244(8):1052-5.
2006: Steven G Potkin; Georges Gharabawi; Andrew Greenspan; Ramy A Mahmoud; Colette Kosik-Gonzalez; Marcia F T Rupnow; Cynthia A Bossie; Michael Davidson; Victoria Burtea; Young Zhu; Jintendra K Trivedi
A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization.
Schizophrenia research 2006;85(1-3):254-65.
2006: Yi Jin; Steven G Potkin; Aaron S Kemp; Steven T Huerta; Gustavo Alva; Trung Minh Thai; Danilo Carreon; William E Bunney
Therapeutic effects of individualized alpha frequency transcranial magnetic stimulation (alphaTMS) on the negative symptoms of schizophrenia.
Schizophrenia bulletin 2006;32(3):556-61.
2006: Rudi Hwang; Takahiro Shinkai; Vincenzo Deluca; Fabio Macciardi; Steven G Potkin; Herbert Y Meltzer; James L Kennedy
Dopamine D2 receptor gene variants and quantitative measures of positive and negative symptom response following clozapine treatment.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2006;16(4):248-59.
2006: Rama Pichika; Balasubramaniam Easwaramoorthy; Daphne Collins; Bradley T Christian; Bingzhi Shi; Tanjore K Narayanan; Steven G Potkin; Jogeshwar Mukherjee
Nicotinic alpha4beta2 receptor imaging agents: part II. Synthesis and biological evaluation of 2-[18F]fluoro-3-[2-((S)-3-pyrrolinyl)methoxy]pyridine (18F-nifene) in rodents and imaging by PET in nonhuman primate.
Nuclear medicine and biology 2006;33(3):295-304.
2006: Roger M Lane; Steven G Potkin; Albert Enz
Targeting acetylcholinesterase and butyrylcholinesterase in dementia.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2006;9(1):101-24.
2006: David Keator; Syam Gadde; Jeffrey S Grethe; Derek V Taylor; Steven G Potkin
A general XML schema and SPM toolbox for storage of neuro-imaging results and anatomical labels.
Neuroinformatics 2006;4(2):199-212.
2006: Steven G Potkin; Gustavo Alva; Ibrahim Gunay; Barbara Koumaras; Michael Chen; Dario Mirski
A pilot study evaluating the efficacy and safety of rivastigmine in patients with mixed dementia.
Drugs & aging 2006;23(3):241-9.
2006: Jessica Turner; Padhraic Smyth; Fabio Macciardi; James H Fallon; James L Kennedy; Steven G Potkin
Imaging phenotypes and genotypes in schizophrenia.
Neuroinformatics 2006;4(1):21-49.
2005: Steven G Potkin; Georges Gharabawi; Andrew Greenspan; Marcia F T Rupnow; Colette Kosik-Gonzalez; Gary Remington; Charles Ruetsch; Dennis Revicki
Psychometric evaluation of the Readiness for Discharge Questionnaire.
Schizophrenia research 2005;80(2-3):203-12.
2005: Takahiro Shinkai; Vincenzo De Luca; Rudi Hwang; Chima Matsumoto; Hiroko Hori; Osamu Ohmori; Gary Remington; Herbert Y Meltzer; Jeffrey A Lieberman; Steven G Potkin; Jun Nakamura; James L Kennedy
Association study between a functional glutathione S-transferase (GSTP1) gene polymorphism (Ile105Val) and tardive dyskinesia.
Neuroscience letters 2005;388(2):116-20.
2005: Steven G Potkin; Paul E Keck; Scott Segal; Kathleen Ice; Patricia English
Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial.
Journal of clinical psychopharmacology 2005;25(4):301-10.
2005: Rudi Hwang; Takahiro Shinkai; Vincenzo De Luca; Daniel J Müller; Xingqun Ni; Fabio Macciardi; Steven G Potkin; Jeffrey A Lieberman; Herbert Y Meltzer; James L Kennedy
Association study of 12 polymorphisms spanning the dopamine D(2) receptor gene and clozapine treatment response in two treatment refractory/intolerant populations.
Psychopharmacology 2005;181(1):179-87.
2005: Mark H Tuszynski; Leon J Thal; Mary Pay; David P Salmon; Hoi Sang U; Roy A E Bakay; Piyush Patel; Armin Blesch; H Lee Vahlsing; Gilbert Ho; Gang Tong; Steven G Potkin; James Fallon; Lawrence A Hansen; Elliott J Mufson; Jeffrey Kordower; Christine M Gall; James Conner
A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease.
Nature medicine 2005;11(5):551-5.
2005: James H Fallon; David Keator; James Mbogori; Derek Taylor; Steven G Potkin
Gender: a major determinant of brain response to nicotine.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2005;8(1):17-26.
2005: Sankha Chattopadhyay; Baogang Xue; Daphne Collins; Rama Pichika; Rudy Bagnera; Frances M Leslie; Bradley T Christian; Bingzhi Shi; Tanjore K Narayanan; Steven G Potkin; Jogeshwar Mukherjee
Synthesis and evaluation of nicotine alpha4beta2 receptor radioligand, 5-(3'-18F-fluoropropyl)-3-(2-(S)-pyrrolidinylmethoxy)pyridine, in rodents and PET in nonhuman primate.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(1):130-40.
2004: Philip D Harvey; Herbert Y Meltzer; George M Simpson; Steven G Potkin; Antony Loebel; Cynthia O Siu; Steven J Romano
Improvement in cognitive function following a switch to ziprasidone from conventional antipsychotics, olanzapine, or risperidone in outpatients with schizophrenia.
Schizophrenia research 2004;66(2-3):101-13.
2004: Larry Alphs; Ravi Anand; M Zahur Islam; Herbert Y Meltzer; John M Kane; Ranga Krishnan; Alan I Green; Steven G Potkin; Guy Chouinard; Jean-Pierre Lindenmayer; Rob Kerwin
The international suicide prevention trial (interSePT): rationale and design of a trial comparing the relative ability of clozapine and olanzapine to reduce suicidal behavior in schizophrenia and schizoaffective patients.
Schizophrenia bulletin 2004;30(3):577-86.
2004: James H Fallon; David Keator; James Mbogori; Jessica Turner; Steven G Potkin
Hostility differentiates the brain metabolic effects of nicotine.
Brain research. Cognitive brain research 2004;18(2):142-8.
2003: Gustavo Alva; Steven G Potkin
Alzheimer disease and other dementias.
Clinics in geriatric medicine 2003;19(4):763-76.
2003: Kirsten Fleming; Susan H Kim; Michael Doo; Gerald Maguire; Steven G Potkin
Memory for emotional stimuli in patients with Alzheimer's disease.
American journal of Alzheimer's disease and other dementias 2003;18(6):340-2.
2003: Steven G Potkin; Larry Alphs; Chuanchieh Hsu; K Ranga Rama Krishnan; Ravi Anand; Frederick K Young; Herbert Y Meltzer; Alan Green
Predicting suicidal risk in schizophrenic and schizoaffective patients in a prospective two-year trial.
Biological psychiatry 2003;54(4):444-52.
2003: Steven G Potkin; Anutosh R Saha; Mary J Kujawa; William H Carson; Mirza Ali; Elyse Stock; Joseph Stringfellow; Gary G Ingenito; Stephen R Marder
Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.
Archives of general psychiatry 2003;60(7):681-90.
2003: Martin R Farlow; Steven G Potkin; Barbara Koumaras; Jeffrey Veach; Dario Mirski
Analysis of outcome in retrieved dropout patients in a rivastigmine vs placebo, 26-week, Alzheimer disease trial.
Archives of neurology 2003;60(6):843-8.
2003: Peter Weiden; George M Simpson; Steven G Potkin; Richard L O'Sullivan
Effectiveness of switching to ziprasidone for stable but symptomatic outpatients with schizophrenia.
The Journal of clinical psychiatry 2003;64(5):580-8.
2003: Paul E Keck; Marcio Versiani; Steven G Potkin; Scott A West; Earl Giller; Kathleen Ice
Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial.
The American journal of psychiatry 2003;160(4):741-8.
2003: S Gauthier; Murat Emre; Martin R Farlow; Roger Bullock; George T Grossberg; Steven G Potkin
Strategies for continued successful treatment of Alzheimer's disease: switching cholinesterase inhibitors.
Current medical research and opinion 2003;19(8):707-14.
2003: Steven G Potkin; Vincenzo S Basile; Yi Jin; Mario Masellis; F Badri; David Keator; Joseph C Wu; Gustavo Alva; Danilo Carreon; William E Bunney; James H Fallon; James L Kennedy
D1 receptor alleles predict PET metabolic correlates of clinical response to clozapine.
Molecular psychiatry 2003;8(1):109-13.
2003: Margherita Molnar; Steven G Potkin; William E Bunney; Edward G Jones
MRNA expression patterns and distribution of white matter neurons in dorsolateral prefrontal cortex of depressed patients differ from those in schizophrenia patients.
Biological psychiatry 2003;53(1):39-47.
2003: Herbert Y Meltzer; Larry Alphs; Alan I Green; A Carlo Altamura; Ravi Anand; Alberto Bertoldi; Marc Bourgeois; Guy Chouinard; M Zahur Islam; John M Kane; Ranga Krishnan; Jean-Pierre Lindenmayer; Steven G Potkin
Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).
Archives of general psychiatry 2003;60(1):82-91.
2003: Steven G Potkin; Ravi Anand; Larry Alphs; Kirsten Fleming
Neurocognitive performance does not correlate with suicidality in schizophrenic and schizoaffective patients at risk for suicide.
Schizophrenia research 2003;59(1):59-66.
2002: Steven G Potkin; Per T Thyrum; Rimal Bera; Danilo Carreon; Gustavo Alva; Amir Kalali; Chiao Yeh
Open-label study of the effect of combination quetiapine/lithium therapy on lithium pharmacokinetics and tolerability.
Clinical therapeutics 2002;24(11):1809-23.
2002: Vincenzo S Basile; Mario Masellis; Steven G Potkin; James L Kennedy
Pharmacogenomics in schizophrenia: the quest for individualized therapy.
Human molecular genetics 2002;11(20):2517-30.
2002: Steven G Potkin; Gustavo Alva; David Keator; Danilo Carreon; Kirsten Fleming; James H Fallon
Brain metabolic effects of Neotrofin in patients with Alzheimer's disease.
Brain research 2002;951(1):87-95.
2002: Katherine A Albert; Hugh C Hemmings; Anna I B Adamo; Steven G Potkin; Schahram Akbarian; Curt A Sandman; Carl W Cotman; William E Bunney; Paul Greengard
Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia.
Archives of general psychiatry 2002;59(8):705-12.
2002: Steven G Potkin; Per T Thyrum; Gustavo Alva; Danilo Carreon; Chiao Yeh; Amir Kalali; Lisa A Arvanitis
Effect of fluoxetine and imipramine on the pharmacokinetics and tolerability of the antipsychotic quetiapine.
Journal of clinical psychopharmacology 2002;22(2):174-82.
2002: Steven G Potkin; Per T Thyrum; Gustavo Alva; Rimal Bera; Chiao Yeh; Lisa A Arvanitis
The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine.
Journal of clinical psychopharmacology 2002;22(2):121-30.
2002: Steven G Potkin; Gustavo Alva; Kirsten Fleming; Ravi Anand; David Keator; Danilo Carreon; Michael Doo; Yi Jin; Joseph C Wu; James H Fallon
A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography.
The American journal of psychiatry 2002;159(2):227-37.
2002: Steven G Potkin
The ABC of Alzheimer's disease: ADL and improving day-to-day functioning of patients.
International psychogeriatrics / IPA 2002;14 Suppl 1():7-26.
2001: Steven G Potkin; Kirsten Fleming; Yi Jin; B Gulasekaram
Clozapine enhances neurocognition and clinical symptomatology more than standard neuroleptics.
Journal of clinical psychopharmacology 2001;21(5):479-83.
2001: Steven G Potkin; Ravi Anand; Kirsten Fleming; Gustavo Alva; David Keator; Danilo Carreon; John Messina; Joseph C Wu; Richard D Hartman; James H Fallon
Brain metabolic and clinical effects of rivastigmine in Alzheimer's disease.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2001;4(3):223-30.
2001: Vincenzo S Basile; Vural Ozdemir; Mario Masellis; Herbert Y Meltzer; Jeffrey A Lieberman; Steven G Potkin; Fabio Macciardi; Arturas Petronis; James L Kennedy
Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia.
Molecular psychiatry 2001;6(2):230-4.
2000: G J Popken; William E Bunney; Steven G Potkin; Edward G Jones
Subnucleus-specific loss of neurons in medial thalamus of schizophrenics.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(16):9276-80.
2000: Vincenzo S Basile; Vural Ozdemir; Mario Masellis; M L Walker; Herbert Y Meltzer; Jeffrey A Lieberman; Steven G Potkin; Gustavo Alva; Werner Kalow; Fabio Macciardi; James L Kennedy
A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: association with tardive dyskinesia in schizophrenia.
Molecular psychiatry 2000;5(4):410-7.
2000: Julie V. Patterson; Yi Jin; M Gierczak; WP Hetrick; Steven G Potkin; William E Bunney; Curt A Sandman
Effects of temporal variability on p50 and the gating ratio in schizophrenia: a frequency domain adaptive filter single-trial analysis.
Archives of general psychiatry 2000;57(1):57-64.
1999: Vincenzo S Basile; Mario Masellis; F Badri; A D Paterson; Herbert Y Meltzer; Jeffrey A Lieberman; Steven G Potkin; Fabio Macciardi; James L Kennedy
Association of the MscI polymorphism of the dopamine D3 receptor gene with tardive dyskinesia in schizophrenia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1999;21(1):17-27.
1999: William E Bunney; WP Hetrick; Blynn G Bunney; Julie V. Patterson; Yi Jin; Steven G Potkin; Curt A Sandman
Structured Interview for Assessing Perceptual Anomalies (SIAPA).
Schizophrenia bulletin 1999;25(3):577-92.
1999: Steven G Potkin; Yi Jin; Blynn G Bunney; J Costa; B Gulasekaram
Effect of clozapine and adjunctive high-dose glycine in treatment-resistant schizophrenia.
The American journal of psychiatry 1999;156(1):145-7.
1998: MM Huntsman; B V Tran; Steven G Potkin; William E Bunney; Edward G Jones
Altered ratios of alternatively spliced long and short gamma2 subunit mRNAs of the gamma-amino butyrate type A receptor in prefrontal cortex of schizophrenics.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(25):15066-71.
1998: Yi Jin; William E Bunney; Curt A Sandman; Julie V. Patterson; Kirsten Fleming; J R Moenter; Amir Kalali; WP Hetrick; Steven G Potkin
Is P50 suppression a measure of sensory gating in schizophrenia?
Biological psychiatry 1998;43(12):873-8.
1998: Yi Jin; Steven G Potkin; Curt A Sandman; William E Bunney
Topographic analysis of EEG photic driving in patients with schizophrenia following clozapine treatment.
Clinical EEG (electroencephalography) 1998;29(2):73-8.
1997: Siu-Wa Tang; Daiga M Helmeste; H Fang; M Li; RL Vu; William E Bunney; Steven G Potkin; Edward G Jones
Differential labeling of dopamine and sigma sites by [3H]nemonapride and [3H]raclopride in postmortem human brains.
Brain research 1997;765(1):7-12.
1997: Yi Jin; Steven G Potkin; Julie V. Patterson; Curt A Sandman; WP Hetrick; William E Bunney
Effects of P50 temporal variability on sensory gating in schizophrenia.
Psychiatry research 1997;70(2):71-81.
1997: Charles Chong-Hwa Hong; Steven G Potkin; J S Antrobus; B M Dow; G M Callaghan; J Christian Gillin
REM sleep eye movement counts correlate with visual imagery in dreaming: a pilot study.
Psychophysiology 1997;34(3):377-81.
1997: Blynn G Bunney; Steven G Potkin; William E Bunney
Neuropathological studies of brain tissue in schizophrenia.
Journal of psychiatric research 1997;31(2):159-73.
1997: Yi Jin; Steven G Potkin; Curt A Sandman; William E Bunney
Electroencephalographic photic driving in patients with schizophrenia and depression.
Biological psychiatry 1997;41(4):496-9.
1996: Daiga M Helmeste; Siu-Wa Tang; W E Bunney; Steven G Potkin; Edward G Jones
Decrease in sigma but no increase in striatal dopamine D4 sites in schizophrenic brains.
European journal of pharmacology 1996;314(3):R3-5.
1996: Yi Jin; Steven G Potkin
P50 changes with visual interference in normal subjects: a sensory distraction model for schizophrenia.
Clinical EEG (electroencephalography) 1996;27(3):151-4.
1996: S Akbarian; J J Kim; Steven G Potkin; WP Hetrick; William E Bunney; Edward G Jones
Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients.
Archives of general psychiatry 1996;53(5):425-36.
1996: Charles Chong-Hwa Hong; Yi Jin; Steven G Potkin; Monte Buchsbaum; J Wu; G M Callaghan; K L Nudleman; J Christian Gillin
Language in dreaming and regional EEG alpha power.
Sleep 1996;19(3):232-5.
1996: J Schroder; Monte Buchsbaum; BV Siegel; F J Geider; J Lohr; C Tang; J Wu; Steven G Potkin
Cerebral metabolic activity correlates of subsyndromes in chronic schizophrenia.
Schizophrenia research 1996;19(1):41-53.
1996: WP Hetrick; Curt A Sandman; William E Bunney; Yi Jin; Steven G Potkin; M H White
Gender differences in gating of the auditory evoked potential in normal subjects.
Biological psychiatry 1996;39(1):51-8.
1996: S Akbarian; N J Sucher; D Bradley; A Tafazzoli; D Trinh; WP Hetrick; Steven G Potkin; Curt A Sandman; William E Bunney; Edward G Jones
Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1996;16(1):19-30.
1995: S Akbarian; MM Huntsman; J J Kim; A Tafazzoli; Steven G Potkin; William E Bunney; Edward G Jones
GABAA receptor subunit gene expression in human prefrontal cortex: comparison of schizophrenics and controls.
Cerebral cortex (New York, N.Y. : 1991) 1995;5(6):550-60.
1995: Yi Jin; Curt A Sandman; J C Wu; J Bernat; Steven G Potkin
Topographic analysis of EEG photic driving in normal and schizophrenic subjects.
Clinical EEG (electroencephalography) 1995;26(2):102-7.
1995: S Akbarian; J J Kim; Steven G Potkin; J O Hagman; A Tafazzoli; William E Bunney; Edward G Jones
Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics.
Archives of general psychiatry 1995;52(4):258-66.
1995: Y Jin; Steven G Potkin; Curt A Sandman
Clozapine increases EEG photic driving in clinical responders.
Schizophrenia bulletin 1995;21(2):263-8.
1994: J Schroeder; Monte Buchsbaum; BV Siegel; F J Geider; Richard J Haier; J Lohr; J Wu; Steven G Potkin
Patterns of cortical activity in schizophrenia.
Psychological medicine 1994;24(4):947-55.
1994: Steven G Potkin; Monte Buchsbaum; Yi Jin; C Tang; J Telford; G Friedman; S Lottenberg; A Najafi; B Gulasekaram; J Costa
Clozapine effects on glucose metabolic rate in striatum and frontal cortex.
The Journal of clinical psychiatry 1994;55 Suppl B():63-6.
1994: Steven G Potkin; R Bera; B Gulasekaram; J Costa; S Hayes; Yi Jin; G Richmond; D Carreon; K Sitanggan; B Gerber
Plasma clozapine concentrations predict clinical response in treatment-resistant schizophrenia.
The Journal of clinical psychiatry 1994;55 Suppl B():133-6.
1994: K M Bell; Steven G Potkin; D Carreon; L Plon
S-adenosylmethionine blood levels in major depression: changes with drug treatment.
Acta neurologica Scandinavica. Supplementum 1994;154():15-8.
1993: BV Siegel; Monte Buchsbaum; William E Bunney; Louis A Gottschalk; Richard J Haier; J B Lohr; S Lottenberg; A Najafi; Keith H Nuechterlein; Steven G Potkin
Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients.
The American journal of psychiatry 1993;150(9):1325-36.
1993: J Wu; Monte Buchsbaum; K Moy; N Denlea; P Kesslak; H Tseng; D Plosnaj; M Hetu; Steven G Potkin; S Bracha
Olfactory memory in unmedicated schizophrenics.
Schizophrenia research 1993;9(1):41-7.
1993: S Akbarian; A Viñuela; J J Kim; Steven G Potkin; William E Bunney; Edward G Jones
Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development.
Archives of general psychiatry 1993;50(3):178-87.
1993: S Akbarian; William E Bunney; Steven G Potkin; Sharon B Wigal; J O Hagman; Curt A Sandman; Edward G Jones
Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development.
Archives of general psychiatry 1993;50(3):169-77.
1993: D H Shapiro; Steven G Potkin; Yi Jin; B Brown; D Carreon; J Wu
Measuring the psychological construct of control. Discriminant, divergent, and incremental validity of the Shapiro Control Inventory and Rotter's and Wallstons' Locus of Control Scales.
International journal of psychosomatics : official publication of the International Psychosomatics Institute 1993;40(1-4):35-46.
1992: Monte Buchsbaum; Steven G Potkin; BV Siegel; J Lohr; M Katz; Louis A Gottschalk; B Gulasekaram; John F Marshall; S Lottenberg; C Y Teng
Striatal metabolic rate and clinical response to neuroleptics in schizophrenia.
Archives of general psychiatry 1992;49(12):966-74.
1992: Monte Buchsbaum; Richard J Haier; Steven G Potkin; Keith H Nuechterlein; H S Bracha; M Katz; J Lohr; J Wu; S Lottenberg; P A Jerabek
Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics.
Archives of general psychiatry 1992;49(12):935-42.
1992: Monte Buchsbaum; Steven G Potkin; John F Marshall; S Lottenberg; C Teng; C W Heh; R Tafalla; C Reynolds; L Abel; L Plon
Effects of clozapine and thiothixene on glucose metabolic rate in schizophrenia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1992;6(3):155-63.
1992: Monte Buchsbaum; Steven G Potkin; B Siegel; William E Bunney; J Lohr; M Katz; Louis A Gottschalk; S Lottenberg; C Teng; L Abel
PET studies of drug interaction with brain regional glucose metabolism.
Clinical neuropharmacology 1992;15 Suppl 1 Pt A():472A-473A.
1990: Monte Buchsbaum; Keith H Nuechterlein; Richard J Haier; J Wu; N Sicotte; Erin A Hazlett; Robert F Asarnow; Steven G Potkin; S Guich
Glucose metabolic rate in normals and schizophrenics during the Continuous Performance Test assessed by positron emission tomography.
The British journal of psychiatry : the journal of mental science 1990;156():216-27.
1990: J Costa; E Khaled; J Sramek; W Bunney; Steven G Potkin
An open trial of glycine as an adjunct to neuroleptics in chronic treatment-refractory schizophrenics.
Journal of clinical psychopharmacology 1990;10(1):71-2.
1990: S J O'Dell; G J La Hoste; C B Widmark; R M Shapiro; Steven G Potkin; John F Marshall
Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptors in rat brain.
Synapse (New York, N.Y.) 1990;6(2):146-53.
1990: Y Jin; Steven G Potkin; D Rice; J Sramek; J Costa; R Isenhart; C Heh; Curt A Sandman
Abnormal EEG responses to photic stimulation in schizophrenic patients.
Schizophrenia bulletin 1990;16(4):627-34.
1989: D M Rice; Steven G Potkin; Y Jin; R Isenhart; C W Heh; J Sramek; J Costa; Curt A Sandman
EEG alpha photic driving abnormalities in chronic schizophrenia.
Psychiatry research 1989;30(3):313-24.
1989: S M Guich; Monte Buchsbaum; L Burgwald; J Wu; Richard J Haier; Robert F Asarnow; Keith H Nuechterlein; Steven G Potkin
Effect of attention on frontal distribution of delta activity and cerebral metabolic rate in schizophrenia.
Schizophrenia research 1989;2(6):439-48.
1989: C W Heh; Steven G Potkin; DAVID PICKAR; J Costa; J Herrera; J Sramek; Edward M DeMet
Serum homovanillic acid concentrations in carbamazepine-treated chronic schizophrenics.
Biological psychiatry 1989;25(5):639-41.
1988: F J Hullett; Steven G Potkin; A B Levy; R Ciasca
Depression associated with nifedipine-induced calcium channel blockade.
The American journal of psychiatry 1988;145(10):1277-9.
1988: K M Bell; L Plon; W E Bunney; Steven G Potkin
S-adenosylmethionine treatment of depression: a controlled clinical trial.
The American journal of psychiatry 1988;145(9):1110-4.
1988: Steven G Potkin; K Bell; L Plon; W E Bunney
Rapid antidepressant response with SAMe. A double-blind study.
The Alabama journal of medical sciences 1988;25(3):313-6.
1988: C W Heh; J Herrera; Edward M DeMet; Steven G Potkin; J Costa; J Sramek; Erin A Hazlett; Monte Buchsbaum
Neuroleptic-induced hypothermia associated with amelioration of psychosis in schizophrenia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1988;1(2):149-56.
1986: Steven G Potkin; R Hahn; J Sramek
Plasma neuroleptic concentration: in search of a therapeutic window.
Clinical neuropharmacology 1986;9 Suppl 4():256-8.